Press Releases | Alaunos

Date	Title and Summary	Additional Formats
Jan 09, 2023	Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023 Announcing addition of two new TCRs to the library, estimated to double the addressable market; plans to further expand TCR library using hunTR® TCR discovery platform Increasing patient enrollment to advance TCR-T Library Program towards Phase 2 using high value TCRs targeting common hotspot